Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer

Cancer Investigation

Volumn 21, Issue 4, 2003, Pages 550-552

  Spell, Derrick W ^a,b   Estephan, Fadi F ^a   Lin, James T ^a   Jones Jr , Dennie V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOCETAXEL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EPIPHORA; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LACRIMAL APPARATUS DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; TAXOIDS;

EID: 0141453737     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120022373     Document Type: Article

References (12)

1. Perez, E.A.; Vogel, C.L.; Irwin, D.H.; Kirshner, J.J.; Patel, R. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J. Clin. Oncol. 2001, 19, 4216-4223.
2. Lynch, T.J., Jr. Review of two phase II randomized trials of single-agent docetaxel in previously treated advanced non-small cell lung cancer. Semin. Oncol. Suppl. 2001, 28 (3 Suppl 9), 5-9.
3. Petrylak, D.P. Docetaxel (taxotere) in hormone-refractory prostate cancer. Semin. Oncol. 2000, 27 (2 Suppl 3), 24-29.
4. Esmaeli, B.; Valero, V.; Ahmadi, M.A.; Booser, D. Canicular stenosis secondary to docetaxel (taxotere). Ophthalmology 2001, 108, 994-995.
5. Esmaeli, B.; Hortobagyi, G.N.; Esteva, F.J.; Booser, D.; Ahmadi, M.A.; Rivera, E.; Arbuckle, R.; Delpassand, E.; Guerra, L.; Valero, V. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer. Ophthalmology 2002, 109, 1188-1191.
6. Esmali, B.; Hortobagyi, G.; Esteva, F.; Valero, V.; Ahmadi, M.A.; Booser, D.; Ibrahim, N.; Delpassand, E.; Arbuckle, R. Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect. Ann. Oncol. 2002, 13, 218-221.
7. Ahmadi, M.A.; Esmaeli, B. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly. Arch. Ophthalmol. 2001, 119, 1802-1804.
8. Haidak, D.J.; Hurwitz, B.S.; Yeung, K.Y. Tear-duct fibrosis (dacryostenosis) due to 5-fluorouracil. Ann. Intern. Med. 1978, 88, 657.
9. Burstein, H.J.; Manola, J.; Younger, J.; Parker, L.M.; Bunnell, C.A.; Scheib, R.; Matulonis, U.A.; Garber, J.E.; Clarke, K.D.; Shulman, L.N.; Winer, E.P. Docetaxel administered on a weekly basis for metastatic breast cancer. J. Clin. Oncol. 2000, 18, 1212-1219.
10. Valero, V.; Holmes, F.A.; Walters, R.S.; Theriault, R.L.; Esparza, L.; Fraschini, G.; Fonseca, G.A.; Bellet, R.E.; Buzdar, A.U.; Hortobagyi, G.N. Phase II trial of docetaxel: a new effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. J. Clin. Oncol. 1995, 13, 2886-2894.
11. Fossella, F.V.; DeVore, R.; Kerr, R.N.; Crawford, J.; Natale, R.R.; Dunphy, F.; Kalman, L.; Miller, V.; Lee, J.S.; Moore, M.; Gandara, D.; Karp, D. ; Vokes, E.; Kris, M.; Kim, Y.; Gamza, F.; Hammershaimb, L. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. J. Clin. Oncol. 2000, 18, 2354-2362.
12. Shepherd, F.A.; Dancey, J.; Ramlau, R.; Mattson, K.; Gralla, R.; O'Rourke, M.; Levitan, N.; Gressot, L.; Vincent, M.; Burkes, R.; Coughlin, S.; Kim, Y.; Berille, J. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J. Clin. Oncol. 2000, 18, 2095-2103.